Aerogen, which develops and manufactures aerosol drug delivery solutions, generated revenue of €92m in 2023 and announced revenues now reaching €150m annually.
The company will create over 1,100 new roles across research and development, manufacturing, science and engineering, ultimately employing more than 1,200 in Ireland.
Aerogen's technology has treated more than 25 million patients globally and aims to expand its biopharmaceuticals business to address newborn respiratory conditions.
Enterprise Ireland reported that 2024 saw client companies creating 15,741 new jobs, with net employment rising by 6,212 across various economic sectors.
Collection
[
|
...
]